Topical Dexamethasone, Ascorbic Acid, and BGP for Enhancing Implant Osseointegration

NCT07060859 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

18

Enrollment

OTHER

Sponsor class

Conditions

Implant Stability and Osseointegration

Interventions

DRUG: Topical Application of Dexamethasone, Ascorbic Acid, and β-Sodium Glycerophosphate

Sponsor

Manar Ziad Foura-Matar